Paper
Organic & Biomolecular Chemistry
13C NMR δ 21.3 (C3), 23 (Cβ), 25.6 (Cγ), 28.2 (Cδ or Cε), 28.3
(Cδ or Cε), 48 (C1), 64.2 (C2), 64.3 (Cα) ppm. HR-ESI-MS: calc.
for C20H42N22+ (M − 2Br) m/z = 155.1669; found 155.1663.
6 A. H. Kamel, T. Y. Soror and F. M. Al Romian, Anal.
Methods, 2012, 4, 3007.
7 A. Cattani, A. Dalla Cort and L. Mandolini, J. Org. Chem.,
1995, 60, 8313.
8 M. Dhaenens, L. Lacombe, J.-M. Lehn and J.-P. Vigneron,
J. Chem. Soc., Chem. Commun., 1984, 1097.
1,10-Bis(N-methylpiperidinium)decane dibromide ([MePip-
(CH2)10MePip]Br2)
9 E. Busseron and J. Rebek Jr., Org. Lett., 2010, 12, 4828.
10 M. D. Pluth, D. Fiedler, J. S. Mugridge, R. G. Bergman,
K. N. Raymond and J. Rebek Jr., Proc. Natl. Acad.
Sci. U. S. A., 2009, 106, 10438.
1
Yield 70%. mp, 264–268 °C. H NMR δ 1.26 (m, 4H, Hε), 1.30
(m, 8H, Hγ and Hδ), 1.60 (qn, J = 6.4 Hz, 4H, H4), 1.69 (m, 4H,
Hβ), 1.81 (m, 8H, H3), 2.95 (s, 6H, CH3), 3.36 (m, 12H, H2 and
Hα), ppm. 13C NMR δ 19.6 (C3), 20.6 (C4), 21 (Cβ), 25.6 (Cγ),
28.2 (Cδ or Cε), 28.3 (Cδ or Cε), 47.8 (CH3), 61.1 (C2), 63.4 (Cα)
11 E. P. Taylor, J. Chem. Soc., 1951, 1950.
12 (a) K. Wengelnik, V. Vidal, M. L. Ancelin, A. M. Cathiard,
J. L. Morgat, C. H. Kocken, M. Calas, S. Herrera,
A. W. Thomas and H. J. Vial, Science, 2002, 295, 1311;
(b) R. Roggero, R. Zufferey, M. Minca, E. Richier, M. Calas,
H. Vial and C. Ben Mamoun, Antimicrob. Agents Chemother.,
2004, 48, 2816.
2+
ppm. HR-ESI-MS: calc. for C22H46N2 (M − 2Br) m/z =
169.1825; found 169.1820.
Methods
The H and 13C NMR spectra were recorded on Bruker Avance
1
400 and 500 spectrometers in D2O. The high-resolution electro-
spray ionization time-of-flight mass spectra were recorded
on a QStar XL QqTOF instrument with an ESI† source. The
host–guest stability constants for the cucurbit[7]uril complexes
with the cationic guests (KCB[7]) were determined by competi-
13 I. Ben Shir, S. Sasmal, T. Mejuch, M. K. Sinha, M. Kapon
and E. Keinan, J. Org. Chem., 2008, 73, 8772.
14 (a) J. Lagona, P. Mukhopadhyay, S. Chakrabarti and
L. Isaacs, Angew. Chem., Int. Ed., 2005, 117, 4922;
(b) K. Kim, N. Selvapalam, Y. H. Ko, K. M. Park, D. Kim and
J. Kim, Chem. Soc. Rev., 2007, 36, 267; (c) L. Isaacs, Chem.
Commun., 2009, 619; (d) E. Masson, X. Ling, R. Joseph,
L. Kyremeh-Mensah and X. Lu, RSC Adv., 2012, 2, 1213.
15 M. V. Rekharsky, T. Mori, C. Yang, Y. H. Ko, N. Selvapalam,
H. Kim, D. Sobransingh, A. E. Kaifer, S. Liu, L. Isaacs,
W. Chen, S. Moghaddam, M. K. Gilson, K. Kim and
Y. Inoue, Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 20737.
16 W. M. Nau, M. Florea and K. I. Assaf, Isr. J. Chem., 2011, 51,
559.
1
tive H NMR binding studies at 298 K as described by Isaacs
and coworkers.31 The solutions were prepared in D2O contain-
ing acetate buffer (0.050 mol dm−3 NaOAc-d3/0.025 mol dm−3
DCl) at pD 4.75 with 3-trimethylsilylpropionic-2,2,3,3-d4 acid
(KCB[7] = (1.82 0.22) × 107 dm3 mol−1),31 tetraethylammonium
bromide ((1.0 0.2) × 106 dm3 mol−1),23 or p-xylylenediamine
((1.84
0.34) × 109 dm3 mol−1 31
) (Sigma-Aldrich, used as
received) as the competing guests. For the determinations of
K1:1 the concentration of CB[7] was less than that of the guest
and the competitor, while for K2:1 the CB[7] concentration was
greater than the concentrations of the guest (to ensure com-
plete formation of the 1 : 1 complex) and the competitor.25,26
17 S. Moghaddam, C. Yang, M. Rekharsky, Y. H. Ko, K. Kim,
Y. Inoue and M. K. Gilson, J. Am. Chem. Soc., 2011, 133,
3570.
18 A. R. Urbach and V. Ramalingam, Isr. J. Chem., 2011, 51,
664.
19 D. H. Macartney, Isr. J. Chem., 2011, 51, 600.
20 I. Ghosh and W. M. Nau, Adv. Drug Delivery Rev., 2012, 64,
764.
Notes and references
1 (a) M. F. Roberts and M. Wink, in Alkaloids: Biochemistry,
Ecology and Medicinal Applications, Plenum, New York, 21 S. Walker, R. Oun, F. J. McInnes and N. J. Wheate,
1998; (b) T. Nogrady and D. Weaver, Medicinal Chemistry: A Isr. J. Chem., 2011, 51, 616.
Molecular and Biochemical Approach, Oxford University 22 I. W. Wyman and D. H. Macartney, Org. Biomol. Chem.,
Press, USA, 2005. 2010, 8, 253.
2 (a) C. Lee, Pharmacol. Ther., 2003, 98, 143; (b) A. S. Akha, 23 A. D. St-Jacques, I. W. Wyman and D. H. Macartney, Chem.
J. Rosa III, J. S. Jahr, A. Li and K. Kiai, Anesthesiol. Clin.,
2010, 28, 691.
3 J. M. Herold, T. J. Wigle, J. L. Norris, R. Lam,
Commun., 2008, 4936.
24 M. A. Gamal-Eldin and D. H. Macartney, Org. Biomol.
Chem., 2013, 11, 488.
V. K. Korboukh, C. Gao, L. A. Ingerman, D. B. Kireev, 25 I. W. Wyman and D. H. Macartney, J. Org. Chem., 2009, 74,
G. Senisterra, M. Vedadi, A. Tripathy, P. J. Brown, 8031.
C. H. Arrowsmith, J. Jin, W. P. Janzen and S. V. Frye, J. Med. 26 I. W. Wyman and D. H. Macartney, Org. Biomol. Chem.,
Chem., 2011, 54, 2504. 2009, 7, 4045.
4 (a) J. L. Anderson, R. Ding, A. Ellern and D. W. Armstrong, 27 I. Majerz, Z. Malarski and T. Lis, J. Mol. Struct., 1991, 243,
J. Am. Chem. Soc., 2005, 127, 593; (b) C. Chiappe,
A. Sanzonea and P. J. Dyson, Green Chem., 2011, 13, 1437.
5 K. Lava, K. Binnemans and T. Cardinaels, J. Phys. Chem. B,
2009, 113, 9506.
351.
28 B. M. Malmström, P.-O. Nyman and L. Strid, J. Chromatogr.,
A, 1981, 215, 109.
29 J. I. Seeman and J. F. Whidby, J. Org. Chem., 1976, 41, 3824.
1240 | Org. Biomol. Chem., 2013, 11, 1234–1241
This journal is © The Royal Society of Chemistry 2013